Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Simões AMC"'
Autor:
Simões AMC; Department of Oncology, National Center for Cancer Immune Therapy (CCIT-DK), Herlev University Hospital, Herlev, Denmark., Holmström MO; Department of Oncology, National Center for Cancer Immune Therapy (CCIT-DK), Herlev University Hospital, Herlev, Denmark., Aehnlich P; Department of Oncology, National Center for Cancer Immune Therapy (CCIT-DK), Herlev University Hospital, Herlev, Denmark., Rahbech A; Department of Oncology, National Center for Cancer Immune Therapy (CCIT-DK), Herlev University Hospital, Herlev, Denmark., Peeters MJW; Department of Oncology, National Center for Cancer Immune Therapy (CCIT-DK), Herlev University Hospital, Herlev, Denmark., Radziwon-Balicka A; Department of Oncology, National Center for Cancer Immune Therapy (CCIT-DK), Herlev University Hospital, Herlev, Denmark., Zamora C; IIB-Sant Pau- Institut Rec. Hospital de la Santa Creu i Sant Pau, Barcelona, Spain., Klausen TW; Department of Oncology, National Center for Cancer Immune Therapy (CCIT-DK), Herlev University Hospital, Herlev, Denmark., Skov V; Department of Hematology, Zealand University Hospital, Roskilde, Denmark., Kjær L; Department of Hematology, Zealand University Hospital, Roskilde, Denmark., Ellervik C; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.; Department of Laboratory Medicine, Boston Children's Hospital, Harvard Medical School, Boston, MA, United States.; Department of Data and Innovation Support, Region Zealand, Sorø, Denmark., Fassi DE; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.; Department of Hematology, Rigshospitalet University Hospital, Copenhagen, Denmark., Vidal S; IIB-Sant Pau- Institut Rec. Hospital de la Santa Creu i Sant Pau, Barcelona, Spain., Hasselbalch HC; Department of Hematology, Zealand University Hospital, Roskilde, Denmark., Andersen MH; Department of Oncology, National Center for Cancer Immune Therapy (CCIT-DK), Herlev University Hospital, Herlev, Denmark.; Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Straten PT; Department of Oncology, National Center for Cancer Immune Therapy (CCIT-DK), Herlev University Hospital, Herlev, Denmark.; Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Publikováno v:
Frontiers in immunology [Front Immunol] 2022 Aug 05; Vol. 13, pp. 970322. Date of Electronic Publication: 2022 Aug 05 (Print Publication: 2022).
Autor:
Kuczek DE; Center for Cancer Immune Therapy, Department of Hematology, Copenhagen University Hospital Herlev, Herlev, Denmark., Larsen AMH; Center for Cancer Immune Therapy, Department of Hematology, Copenhagen University Hospital Herlev, Herlev, Denmark.; Roskilde University Center, Roskilde, Denmark., Thorseth ML; Center for Cancer Immune Therapy, Department of Hematology, Copenhagen University Hospital Herlev, Herlev, Denmark., Carretta M; Center for Cancer Immune Therapy, Department of Hematology, Copenhagen University Hospital Herlev, Herlev, Denmark., Kalvisa A; Department of Biochemistry and Molecular Biology, University of Southern Denmark, Odense, Denmark., Siersbæk MS; Department of Biochemistry and Molecular Biology, University of Southern Denmark, Odense, Denmark., Simões AMC; Center for Cancer Immune Therapy, Department of Hematology, Copenhagen University Hospital Herlev, Herlev, Denmark., Roslind A; Department of Pathology, Copenhagen University Hospital Herlev, Herlev, Denmark., Engelholm LH; Finsen Laboratory, Biotech Research and Innovation Centre, University of Copenhagen, Copenhagen, Denmark., Noessner E; Immunoanalytics: Tissue control of Immunocytes, German Research Center for Environmental Health, Helmholtz Zentrum München, Munich, Germany., Donia M; Center for Cancer Immune Therapy, Department of Hematology, Copenhagen University Hospital Herlev, Herlev, Denmark., Svane IM; Center for Cancer Immune Therapy, Department of Hematology, Copenhagen University Hospital Herlev, Herlev, Denmark., Straten PT; Center for Cancer Immune Therapy, Department of Hematology, Copenhagen University Hospital Herlev, Herlev, Denmark.; Institute for Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark., Grøntved L; Department of Biochemistry and Molecular Biology, University of Southern Denmark, Odense, Denmark., Madsen DH; Center for Cancer Immune Therapy, Department of Hematology, Copenhagen University Hospital Herlev, Herlev, Denmark. daniel.hargboel.madsen@regionh.dk.; Department of Oncology, Copenhagen University Hospital Herlev, Herlev, Denmark. daniel.hargboel.madsen@regionh.dk.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2019 Mar 12; Vol. 7 (1), pp. 68. Date of Electronic Publication: 2019 Mar 12.
Autor:
Santegoets SJAM; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands., de Groot AF; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands., Dijkgraaf EM; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands., Simões AMC; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands., van der Noord VE; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands., van Ham JJ; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands., Welters MJP; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands., Kroep JR; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands., van der Burg SH; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands.
Publikováno v:
Oncoimmunology [Oncoimmunology] 2018 May 31; Vol. 7 (8), pp. e1465166. Date of Electronic Publication: 2018 May 31 (Print Publication: 2018).